Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

PURPOSE: There is a considerable variability in the level of molecular responses achieved with imatinib therapy in patients with chronic myeloid leukemia (CML). These differences could result from variable therapy adherence. METHODS: Eighty-seven patients with chronic-phase CML treated with imatinib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Marin, David, Bazeos, Alexandra, Mahon, Francois-Xavier, Eliasson, Lina, Milojkovic, Dragana, Bua, Marco, Apperley, Jane F., Szydlo, Richard, Desai, Ritti, Kozlowski, Kasia, Paliompeis, Christos, Latham, Victoria, Foroni, Letizia, Molimard, Mathieu, Reid, Alistair, Rezvani, Katy, de Lavallade, Hugues, Guallar, Cristina, Goldman, John, Khorashad, Jamshid S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6366340/
https://ncbi.nlm.nih.gov/pubmed/20385986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.3087
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados